Aeternum Health, Inc. AETN

FY2025 · ended Dec 31, 2025 · Revenue $203,655, +212.7% YoY · Filed Mar 31, 2026

Aeternum Health, Inc. (AETN) files with the SEC under industry code 3690, Miscellaneous Electrical Machinery, Equipment & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $203,655 and a net loss of $337,094.

Revenue (TTM)
$41,258
-81.1% vs year-ago TTM
Net income (TTM)
$-482,640
-46.5% vs year-ago TTM
Operating cash flow (TTM)
$-1.58M
-17269.0% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.01
Dividend per share
None
Shares outstanding
52.19M
+6.1% vs prior year
Net cash
—
Operating margin
-997.5%
FY 2026

Company profile

Industry
Miscellaneous Electrical Machinery, Equipment & Supplies (SIC 3690)
Listed as
AETN (OTC), AETND (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hillsboro, OR
SEC filer status
, Emerging growth company
SEC CIK
764630
Former names
SHOREPOWER TECHNOLOGIES INC. (until May 15, 2026); UNITED STATES BASKETBALL LEAGUE INC (until Jun 22, 2023)

Other Miscellaneous Electrical Machinery, Equipment & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2024
Feb 29, 2024
FY 2023
Feb 28, 2023
FY 2022
Feb 28, 2022
Revenue
$203,655
$65,121
$19,610
—
$5,000
Operating income
-$269,274
-$430,489
-$584,240
-$258,524
-$304,035
Net income
-$337,094
-$450,318
-$661,965
-$315,524
-$2.1M
Diluted EPS
-$0.01
-$0.01
-$0.01
—
-$0.36
Operating cash flow
-$2,958
-$154,046
-$341,607
-$303,332
-$117,989
Total assets
$54,557
$65,417
$209,379
$676,266
$212,964
Total liabilities
$2.1M
$1.7M
$1.5M
$1.5M
$13,478
Stockholders' equity
-$2.0M
-$1.7M
-$1.3M
-$846,521
-$1.6M
Cash and investments
$0
$0
$0
$0
$0

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 25, 2026 Sep 21, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 1, 2026 Jul 31, 2026
10-Q Quarterly report Aug 19, 2026 Jun 30, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 13, 2026 Aug 7, 2026
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change
Jul 7, 2026 Jun 30, 2026
10-Q Quarterly report May 19, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.